Cited by 919Neurogenesis and neuroplasticity mechanismsMultiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index; 23 of the 48 sources its claims cite were checked for support.

Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling

Open access

Abstract

Oligodendrocyte precursors (OPs) continue to proliferate and generate myelinating oligodendrocytes (OLs) well into adulthood. It is not known whether adult-born OLs ensheath previously unmyelinated axons or remodel existing myelin. We quantified OP division and OL production in different regions of the adult mouse CNS including the 4-month-old optic nerve, in which practically all axons are already myelinated. Even there, all OPs were dividing and generating new OLs and myelin at a rate higher than can be explained by first-time myelination of naked axons. We conclude that adult-born OLs in the optic nerve are engaged in myelin remodeling, either replacing OLs that die in service or intercalating among existing myelin sheaths. The latter would predict that average internode length should decrease with age. Consistent with that, we found that adult-born OLs elaborated much shorter but many more internodes than OLs generated during early postnatal life.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Adult mouse oligodendrocyte precursors continue dividing and generating new oligodendrocytes even in the almost fully myelinated optic nerve. Adult-born oligodendrocytes elaborate many more, shorter internodes than early-born oligodendrocytes, suggesting myelin remodeling rather than only de novo myelination.

Key findings

  • All OPs were cycling throughout the adult CNS (growth fraction ≈100%), with cell-cycle time depending on region and age: at P60, ~10 days in corpus callosum, ~15 days in spinal cord white matter, ~20 days in optic nerve, and ~36 days in cortical gray matter.
  • In optic nerve, ~6.5% ± 1.5% of CC1+ oligodendrocytes at P185 were born after P120, far exceeding the ~1% of axons still unmyelinated, implying adult-born OLs are engaged in myelin remodeling.
  • Late-born OLs (P120–P185) had 77 ± 7 internodes per OL of mean length 22 ± 1 μm, whereas early-born OLs (P30–P60) had 21 ± 7 internodes of mean length 76 ± 2 μm; total myelin length per cell was similar (~1,700 μm vs. ~1,600 μm).
  • Newly formed myelin after P120 had a slightly higher g-ratio (0.75 ± 0.06) than myelin formed after P30 (0.72 ± 0.05), and >94% of examined mGFP+ internodes were Caspr+.

Methods

  • Used cumulative EdU labeling and Pdgfra-CreERT2 fate mapping with R26R-YFP or Tau-mGFP reporters in postnatal and adult mice, including tamoxifen administration at P45, P60, and P120.
  • Quantified OP labeling index, cell-cycle time, OL differentiation, internode number/length by confocal microscopy, and myelin morphology/g-ratio by immunoelectron microscopy.
  • Conducted simulations of conduction speed based on previously published models.

Limitations

  • The paper states that survival calculations have considerable uncertainty concerning the rate of increase of cell-cycle time with age and may underestimate the proportion of new OLs that survive; it also states that it is not yet known whether significant OL or myelin turnover occurs during the first year of life in mice.
  • Evident from the text: conclusions are based on mouse CNS regions, primarily optic nerve, corpus callosum, spinal cord, and cortex, so generalization to other species or regions is not established.
  • Evident from the text: tamoxifen recombination labels only a subset of OPs (~20% in optic nerve; ~4% in Tau-mGFP optic nerves), and internode counts required a sampling correction because section thickness was less than the OL process field diameter.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2013.01.006

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

23 of 48 cited sources checked · 10 supported · 0 flagged · accuracy not yet measured

Show all 76 claims

  • It may state two separate claims as one. 34
  • Probably not a substantial claim. 11
42 of 42
  • The paper relies on this without support.

    The fraction of OPs labeled by tamoxifen induction (approximately 20%) is representative of all OPs, so the proportion of all CC1+ cells born after P120 can be estimated by dividing the YFP+ CC1+ fraction by 0.20.

    “Because only ∼20% of OPs were YFP-labeled by tamoxifen induction, this implies that 6.5% ± 1.5% [(1.3 ± 0.3) × 100/20] of all CC1+ cells in the P185 optic nerve are born after P120.”
  • The authors state this as an assumption.

    The cell-cycle time continues to increase linearly with age after P60 at the same rate that it increases between P21 and P60.

    “assuming that the cell-cycle time continues to increase linearly with age after P60 at the same rate that it increases between P21 and P60 (Table 1)”
  • The authors state this as an assumption.

    All additional cells produced by OP divisions would differentiate into OLs and survive.

    “If all of these additional cells were to differentiate into OLs and survive”
  • The authors state this as an assumption.

    mGFP+ and GFP-negative OLs are equally likely to survive.

    “assuming that mGFP+ and GFP-negative OLs are equally likely to survive”
  • The paper relies on this without support.

    On average one new OL and one replacement OP is formed for every OP division.

    “because on average one new OL and one replacement OP is formed for every OP division”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 56 references

1 of the 56 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 601–700 of 874

Metadata

Authors
Young, K. M., Psachoulia, K., Tripathi, R. B., Dunn, S.-J., Cossell, L., Attwell, D., Tohyama, K., & Richardson, W. D.
Affiliations
  • University of Tasmania (AU)
  • University College London (GB)
  • Microsoft Research (United Kingdom) (GB)
  • Iwate Medical University (JP)
Corresponding author
Richardson, William D.
Venue
Neuron
Publisher
Elsevier BV
Published
2013-03
Volume
77
Issue
5
Pages
873-885
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2065770359
Cited by
919
References
56
Citations by year
2026: 57 · 2025: 57 · 2024: 53 · 2023: 50 · 2022: 60 · 2021: 96 · 2020: 69 · 2019: 83 · 2018: 76 · 2017: 98 · 2016: 72 · 2015: 62 · 2014: 58 · 2013: 27
FWCI
21.55
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Health and Medical Research Council
  • Medical Research Council
  • Ministry of Education, Culture, Sports, Science and Technology
  • Bupa Foundation
  • Alzheimer’s Society
  • National Institutes of Health
  • Wellcome Trust
  • Multiple Sclerosis Research Australia
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
oligodendrocyte precursor cells, myelin remodeling, adult neurogenesis, oligodendrocyte proliferation, optic nerve, internode length, myelination, axonal myelination, oligodendrocyte death, central nervous system development
MeSH terms
Aging, Animals, Cell Count, Cell Cycle, Cell Differentiation, Cell Division, Cell Survival, Central Nervous System, Immunohistochemistry, Mice, Transgenic, Myelin Sheath, Oligodendroglia, Optic Nerve, Polymerase Chain Reaction, Microscopy, Immunoelectron, Microscopy, Confocal, Receptor, Platelet-Derived Growth Factor alpha, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review